NCT05930002View on ClinicalTrials.gov

Role of Ivermectin and Colchicine in Treatment of COVID-19: Randomized Controlled Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 21, 2021

Primary Completion Date

September 9, 2022

Study Completion Date

December 28, 2022

Conditions
COVID-19
Interventions
DRUG

Ivermectin Tablets

oral tablets (0.2 mg/kg/day) single dose on an empty stomach for three successive days.

DRUG

Colchicine 0.5 MG

0.5mg tablets (3times/day after meal for 3 days then twice daily for 4 days)

DRUG

Standared managment

(Vitamin C 500mg tablet twice daily, Vitamin D3 2000-4000 IU/day, Zinc 75mg tablet once daily for two weeks

Trial Locations (1)

Unknown

Ain shams university, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05930002 - Role of Ivermectin and Colchicine in Treatment of COVID-19: Randomized Controlled Clinical Trial | Biotech Hunter | Biotech Hunter